Proactive Investors - Run By Investors For Investors

Supreme Pharma poised to sell almost all 2016 output

If the deals turn into definite agreements, it would mean the sale of more than 250kg of dried marijuana and 70 kg of dried marijuana trim in 2016
Pictured is the firm's state-of-the-art growing facility
The group has now secured letters of intent (LOIs) with five licenced producers over the long term supply

Medical marijuana grower Supreme Pharmaceuticals Inc (CSE:SL) is on a roll.

It has now secured letters of intent (LOIs) with five licenced producers over the long term supply of marijuana.

If they turn into definite agreements, it would mean the sale of more than 250kg of dried marijuana and 70 kg of dried marijuana trim in 2016, representing pretty much all of the group subsidiary's anticipated production for 2016, the firm said.

In addition, the agreements will be renewable for successive one-year periods.

John Fowler, Supreme's president and chief executive, told investors: "These LOIs validate our B2B business model, leveraging our competitive advantage as a single-licence producer operating one of the largest, most innovative production facilities in the country.

"Our goal is to support aggregate growth in the industry by providing leading retailers with high-quality, sun-grown cannabis and today is the first step towards that goal."

Supreme is the first LP in Canada to focus exclusively on a B2B model intended to provide stable, long-term supply to retail focused LPs, it added.

The deals are conditional upon various factors, including gaining regulatory approvals, a sales licence and completion of due diligence.

Last month the group struck a strategic tie-up with  top Spanish international cannabis seed developer. Dinafem Seeds, which will supply Supreme's wholly owned subsidiary, AMMCan with seeds to be used in the group's seven-acre (342,000-square-foot) facility in Ontario.

Dinafem will also supply Supreme with exclusive continuing consulting services.

That news comes hot on the heels of the new opening of Supreme's new greenhouse.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full SL profile View Profile

Supreme Pharmaceuticals Timeline

Related Articles

scientist at petrie dish
Wed
Here we take a closer look at Midatech Pharma PLC (LON:MTPH)
Enzymes under a microscope
April 28 2019
The Florida company applies its proprietary C1 gene expression platform to speed up the development of biologic vaccines, drugs at flexible commercial scales
Oncoprex
October 17 2018
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use